← E76

Chapter 4 - Endocrine, nutritional and metabolic diseases (E00-E89)»Metabolic disorders (E70-E88)»Mucopolysaccharidosis, type II (E76.1)

E76.1

Mucopolysaccharidosis, type II

Related indications (MeSH) (1)

Mucopolysaccharidosis II26 drugs (13 approved, 13 experimental)

Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.